Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta-chain constant region 2 is one of two nearly identical constant region genes (TRBC1, TRBC2) within the human TCR beta-chain locus on chromosome 7[1][9]. The TCR beta chain is a critical component of the T cell receptor complex, which is a membrane-bound heterodimeric protein involved in recognizing antigen peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells[3][5][7]. The constant region 2, like constant region 1, helps to form the structural backbone that stabilizes the beta chain and anchors it within the T cell membrane, facilitating signal transduction when the TCR is engaged by peptide-MHC[1][3][5]. The presence of two near-identical constant region genes likely arises from an ancient gene duplication event[1][9]. TRBC2 is occasionally targeted in immunophenotyping assays to track clonal T cells or distinguish populations in research or diagnostics. While not a common direct drug target, its integrity and proper expression are essential for normal TCR function and therefore for any therapeutic applications involving engineered TCRs.
TCR engineering: Transfer of TCRs with defined specificity into patients’ T cells to target cancer antigen peptides presented on MHCs, depending on the proper structure/function of TCR alpha and beta chains (including constant region 2). No direct ligand/drug with a defined mechanism of action specific for the beta-chain constant region 2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta-chain constant region 2 (TRBC2).